Matthew Cortese, MD, MPH, discusses the next steps for the multiomic evaluation of venetoclax activity in chronic lymphocytic leukemia.
Matthew Cortese, MD, MPH
Advertisement
Matthew Cortese, MD, MPH, is an assistant professor in the Department of Medicine–Lymphoma and Department of Cancer Genetics and Genomics at Roswell Park Comprehensive Cancer Center.
Articles by Matthew Cortese, MD, MPH
Matthew Cortese, MD, MPH, discusses the rationale for an analysis of the immunologic activity of venetoclax in patients with chronic lymphocytic leukemia.
Matthew Cortese, MD, MPH, discusses the methods used to produce a comprehensive map of immune changes that occur with venetoclax treatment in CLL.
Matthew Cortese, MD, MPH, discusses the benefit of analyzing multiple biological layers when identifying immunologic changes in CLL after venetoclax.
Matthew Cortese, MD, MPH, discusses the immunologic changes observed with venetoclax in patients with CLL.
Advertisement
Latest Updated Articles
Dr Cortese on Methods for Evaluating immunologic Changes With Venetoclax in CLLPublished: April 11th 2025 | Updated:
- Dr Cortese on the Benefits of a Multiomic Evaluation of Immunologic Changes in CLL After Venetoclax
Published: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
4
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
5